DrugPatentWatch Database Preview
Profile for Canada Patent: 2787568
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2787568
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
Start Trial | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
Start Trial | Aug 11, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
Start Trial | Aug 11, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
Start Trial | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
Start Trial | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
Start Trial | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |